Drugmaker Nostrum and Its CEO

MA 2023 Independent Pharmacies

DOJ False Claims Act

Penalty

$50 million

Outcome

Drugmaker Nostrum and Its CEO Agree to Pay Up to $50 Million to Settle False Claims Act Claims for Underpaying Rebates Owed Under Medicaid Drug Rebate Program

Details

Drugmaker Nostrum and Its CEO — DOJ Enforcement (2023)

Outcome: Drugmaker Nostrum and Its CEO Agree to Pay Up to $50 Million to Settle False Claims Act Claims for Underpaying Rebates Owed Under Medicaid Drug Rebate Program

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted.

Source: DOJ Press Release — Drugmaker Nostrum and Its CEO Agree to Pay Up to $50 Million to Settle False Claims Act Claims for Underpaying Rebates Owed Under Medicaid Drug Rebate

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works